172 related articles for article (PubMed ID: 9333016)
1. Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model.
Kogerman P; Sy MS; Culp LA
Oncogene; 1997 Sep; 15(12):1407-16. PubMed ID: 9333016
[TBL] [Abstract][Full Text] [Related]
2. Plasticity of CD44s expression during progression and metastasis of fibrosarcoma in an animal model system.
Culp LA; Kogerman P
Front Biosci; 1998 Jul; 3():d672-83. PubMed ID: 9634540
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of human CD44s in murine 3T3 cells: selection against during primary tumorigenesis and selection for during micrometastasis.
Kogerman P; Sy MS; Culp LA
Clin Exp Metastasis; 1998 Jan; 16(1):83-93. PubMed ID: 9502080
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: facilitated retention in the lung vasculature.
Kogerman P; Sy MS; Culp LA
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13233-8. PubMed ID: 9371829
[TBL] [Abstract][Full Text] [Related]
5. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
6. CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene.
Kogerman P; Sy MS; Culp LA
J Cell Physiol; 1996 Nov; 169(2):341-9. PubMed ID: 8908201
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
8. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
Radinsky R; Kraemer PM; Proffitt MR; Culp LA
Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
10. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
[TBL] [Abstract][Full Text] [Related]
11. Transient alterations in the expression of protease and extracellular matrix genes during metastatic lung colonization by H-ras-transformed 10T1/2 fibroblasts.
Gingras MC; Jarolim L; Finch J; Bowden GT; Wright JA; Greenberg AH
Cancer Res; 1990 Jul; 50(13):4061-6. PubMed ID: 2191771
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine.
Rimoldi D; Srikantan V; Wilson VL; Bassin RH; Samid D
Cancer Res; 1991 Jan; 51(1):324-30. PubMed ID: 1703037
[TBL] [Abstract][Full Text] [Related]
13. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
14. Different metastatic potentials of ras- and src-transformed BALB/c 3T3 A31 variant cells.
Tatsuka M; Ota T; Yamagishi N; Kashihara Y; Wada M; Matsuda N; Mitsui H; Seiki M; Odashima S
Mol Carcinog; 1996 Apr; 15(4):300-8. PubMed ID: 8634088
[TBL] [Abstract][Full Text] [Related]
15. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
Sonobe MH; Bravo R; Armelin MS
Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
17. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells.
Nam SW; Clair T; Campo CK; Lee HY; Liotta LA; Stracke ML
Oncogene; 2000 Jan; 19(2):241-7. PubMed ID: 10645002
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous metastasis of rat liver epithelial cells transformed with v-raf and v-raf/v-myc: association with different phenotypic properties.
Bisgaard HC; Mackay AR; Gomez DE; Ton PT; Thorgeirsson SS; Thorgeirsson UP
Invasion Metastasis; 1997; 17(5):240-50. PubMed ID: 9876218
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
[TBL] [Abstract][Full Text] [Related]
20. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.
Radinsky R; Flickinger KS; Kosir MA; Zardi L; Culp LA
Cancer Res; 1990 Jul; 50(14):4388-400. PubMed ID: 2163749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]